1
|
Hopple AM, Doro KO, Bailey VL, Bond-Lamberty B, McDowell N, Morris KA, Myers-Pigg A, Pennington SC, Regier P, Rich R, Sengupta A, Smith R, Stegen J, Ward ND, Woodard SC, Megonigal JP. Attaining freshwater and estuarine-water soil saturation in an ecosystem-scale coastal flooding experiment. Environ Monit Assess 2023; 195:425. [PMID: 36826723 PMCID: PMC9958149 DOI: 10.1007/s10661-022-10807-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Accepted: 12/02/2022] [Indexed: 06/18/2023]
Abstract
Coastal upland forests are facing widespread mortality as sea-level rise accelerates and precipitation and storm regimes change. The loss of coastal forests has significant implications for the coastal carbon cycle; yet, predicting mortality likelihood is difficult due to our limited understanding of disturbance impacts on coastal forests. The manipulative, ecosystem-scale Terrestrial Ecosystem Manipulation to Probe the Effects of Storm Treatments (TEMPEST) experiment addresses the potential for freshwater and estuarine-water disturbance events to alter tree function, species composition, and ecosystem processes in a deciduous coastal forest in MD, USA. The experiment uses a large-unit (2000 m2), un-replicated experimental design, with three 50 m × 40 m plots serving as control, freshwater, and estuarine-water treatments. Transient saturation (5 h) of the entire soil rooting zone (0-30 cm) across a 2000 m2 coastal forest was attained by delivering 300 m3 of water through a spatially distributed irrigation network at a rate just above the soil infiltration rate. Our water delivery approach also elevated the water table (typically ~ 2 m belowground) and achieved extensive, low-level inundation (~ 8 cm standing water). A TEMPEST simulation approximated a 15-cm rainfall event and based on historic records, was of comparable intensity to a 10-year storm for the area. This characterization was supported by showing that Hurricane Ida's (~ 5 cm rainfall) hydrologic impacts were shorter (40% lower duration) and less expansive (80% less coverage) than those generated through experimental manipulation. Future work will apply TEMPEST treatments to evaluate coastal forest resilience to changing hydrologic disturbance regimes and identify conditions that initiate ecosystem state transitions.
Collapse
Affiliation(s)
- A. M. Hopple
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
- Smithsonian Environmental Research Center, Edgewater, MD 21037 USA
| | - K. O. Doro
- University of Toledo, Toledo, OH 43606 USA
| | - V. L. Bailey
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - B. Bond-Lamberty
- Joint Global Change Research Institute, Pacific Northwest National Laboratory, College Park, MD 20740 USA
| | - N. McDowell
- Atmospheric Science and Global Change Division, Pacific Northwest National Laboratory, WA 99352 Richland, USA
- School of Biological Sciences, Washington State University, Pullman, WA 99164 USA
| | - K. A. Morris
- Joint Global Change Research Institute, Pacific Northwest National Laboratory, College Park, MD 20740 USA
| | - A. Myers-Pigg
- University of Toledo, Toledo, OH 43606 USA
- Marine and Coastal Research Laboratory, Pacific Northwest National Laboratory, Sequim, WA 98382 USA
| | - S. C. Pennington
- Joint Global Change Research Institute, Pacific Northwest National Laboratory, College Park, MD 20740 USA
| | - P. Regier
- Marine and Coastal Research Laboratory, Pacific Northwest National Laboratory, Sequim, WA 98382 USA
| | - R. Rich
- Smithsonian Environmental Research Center, Edgewater, MD 21037 USA
| | - A. Sengupta
- California Lutheran University, Thousand Oaks, CA 91360 USA
| | - R. Smith
- Global Aquatic Research LLC, Sodus, NY 14551 USA
| | - J. Stegen
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - N. D. Ward
- Marine and Coastal Research Laboratory, Pacific Northwest National Laboratory, Sequim, WA 98382 USA
- University of Washington, Seattle, WA 98195 USA
| | | | - J. P. Megonigal
- Smithsonian Environmental Research Center, Edgewater, MD 21037 USA
| |
Collapse
|
2
|
Jex N, Chowdhary A, Thirunavukarasu S, Procter H, Sengupta A, Natarajan P, Kotha S, Poenar AM, Xue H, Cubbon R, Kellman P, Greenwood JP, Plein S, Page SP, Levelt E. Coexistent diabetes is associated with the presence of adverse phenotypic features in patients with hypertrophic cardiomyopathy. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Type 2 diabetes mellitus (DM) is associated with worsened clinical outcomes in hypertrophic cardiomyopathy (HCM) patients. The reasons for this adverse prognostic association are incompletely understood. Although distinct entities both HCM and DM share common features of impaired myocardial energetics and coronary microvascular function.
Purpose
We sought to test the hypothesis that co-existent diabetes is associated with greater reductions in myocardial energetics and perfusion, and higher scar burden in HCM.
Research design and methods
Seventy-five age- and sex-matched participants with concomitant HCM and DM (HCM-DM, n=20), isolated HCM (n=20), isolated DM (n=20) and healthy volunteers (HV, n=15) underwent 31phosphorus magnetic resonance spectroscopy and cardiovascular magnetic resonance imaging. The HCM groups were matched for HCM phenotype. The DM groups were matched for diabetes treatment, duration, HbA1c, body mass index and hypertension comorbidity.
Results
ESC sudden cardiac death risk scores were comparable between the HCM groups (HCM: 2.2±1.5%, HCM-DM: 1.9±1.2%; p=NS) and sarcomeric mutations were equally common. HCM-DM had the highest NT-proBNP levels (HV: 42 ng/L [IQR: 35–66], DM: 118 ng/L [IQR: 53–187], HCM: 298 ng/L [IQR: 157–837], HCM-DM: 726 ng/L [IQR: 213–8695]; p<0.0001). Left-ventricular ejection fraction, mass and wall thickness were similar between the HCM groups. HCM-DM displayed a greater degree of fibrosis burden with higher scar percentage, and lower global longitudinal strain compared to the isolated HCM. PCr/ATP was similarly decreased in the HCM-DM and DM (HV: 2.17±0.49, DM: 1.61±0.23, HCM: 1.93±0.38, HCM-DM: 1.54±0.27; p=0.0003). HCM-DM had the lowest stress myocardial blood flow (HV: 2.06±0.42 ml/min/g, DM: 1.78±0.45 ml/min/g, HCM: 1.74±0.44 ml/min/g, HCM-DM: 1.39±0.42 ml/min/g; p=0.004).
Conclusions
We show for the first time that HCM patients with DM comorbidity display greater reductions in myocardial energetics, perfusion, contractile function and higher myocardial scar burden and serum NT-proBNP levels compared to patients with isolated HCM despite similar LV mass and wall thickness and presence of sarcomeric mutations. These adverse phenotypic features may be important components of the adverse clinical manifestation attributable to a combined presence of HCM and DM.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Diabetes UK
Collapse
Affiliation(s)
- N Jex
- University of Leeds , Leeds , United Kingdom
| | - A Chowdhary
- University of Leeds , Leeds , United Kingdom
| | | | - H Procter
- Leeds General Infirmary, Cardiology , Leeds , United Kingdom
| | - A Sengupta
- Leeds General Infirmary, Cardiology , Leeds , United Kingdom
| | - P Natarajan
- University of Leeds , Leeds , United Kingdom
| | - S Kotha
- University of Leeds , Leeds , United Kingdom
| | - A M Poenar
- Leeds General Infirmary, Cardiology , Leeds , United Kingdom
| | - H Xue
- National Heart Lung and Blood Institute , Bethesda , United States of America
| | - R Cubbon
- University of Leeds , Leeds , United Kingdom
| | - P Kellman
- National Heart Lung and Blood Institute , Bethesda , United States of America
| | | | - S Plein
- University of Leeds , Leeds , United Kingdom
| | - S P Page
- Leeds General Infirmary, Cardiology , Leeds , United Kingdom
| | - E Levelt
- University of Leeds , Leeds , United Kingdom
| |
Collapse
|
3
|
Cannie D, Protonotarios A, Syrris P, Sengupta A, Bilinska Z, Arana Achaga X, Barriales-Villa R, Garcia-Pavia P, Gimeno J, Merlo M, Wahbi K, Fatkin D, Mogensen J, Rasmussen TB, Elliott P. Influence of sex on cardiovascular outcomes in RBM20 variant carriers. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Variants in the RBM20 gene cause dilated cardiomyopathy and may be associated with a poor prognosis.
Objectives
To determine disease penetrance, the risk of adverse events and the influence of sex on outcomes in RBM20 variant carriers.
Methods
Consecutive probands and relatives carrying pathogenic or likely pathogenic RBM20 variants were retrospectively recruited from 12 cardiomyopathy units. The primary endpoint was a composite of malignant ventricular arrhythmia (MVA) and end-stage heart failure (ESHF). MVA and ESHF endpoints were also analysed separately and males and females compared.
Results
Longitudinal follow-up data were available for 163 RBM20 variant carriers (82 male, median age 36.5 years, median follow-up 77.6 months). 10/163 had an MVA event at baseline. 30/153 without baseline MVA (19.6%) reached the primary endpoint with a trend towards worse outcomes in males (p=0.08). 16/153 (10.5%) had new MVA with no difference between males and females (p=0.92). 20/163 (12.2%) developed ESHF (17 males and 3 females; p<0.001).
By the end of follow-up, 114 patients (70%) had either left ventricular systolic dysfunction (LVSD) or had experienced MVA. 22 patients received a first diagnosis of LVSD during follow-up. Disease penetrance in individuals over 40 years of age was 78.5% by last evaluation.
Eleven patients that reached the MVA endpoint had a left ventricular ejection fraction (LVEF) available within 6 months of the event. Median [IQR] contemporary LVEF was 30% [23.75, 40%]. 5/11 patients had a contemporary LVEF >35%. 1/11 had a contemporary LVEF >45% (a female, 1st degree relative presenting with sustained ventricular tachycardia and an LVEF of 65%).
Conclusions
RBM20 variants are highly penetrant. The risk of MVA in male and female RBM20 variant carriers is similar but male sex is strongly associated with ESHF. MVA events occur in patients with LVEF >35%.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): British Heart Foundation Clinical Research Training Fellowship
Collapse
Affiliation(s)
- D Cannie
- University College London & Barts Heart Centre , London , United Kingdom
| | - A Protonotarios
- University College London & Barts Heart Centre , London , United Kingdom
| | - P Syrris
- University College London , London , United Kingdom
| | - A Sengupta
- Yorkshire Heart Centre , Leeds , United Kingdom
| | - Z Bilinska
- Institute of Cardiology, Unit for Screening Studies in Inherited Cardiovascular Disease , Warsaw , Poland
| | - X Arana Achaga
- University Hospital Donostia, Heart Failure and Inherited Cardiac Diseases , Donostia , Spain
| | - R Barriales-Villa
- Universidade da Coruna, Instituto de Investigaciόn Biomédica de A Coruña (INIBIC/ CIBERCV) , A Coruna , Spain
| | - P Garcia-Pavia
- Hospital Universitario Puerta de Hierro, IDIPHISA, CIBERCV, Heart Failure and Inherited Cardiac Diseases Unit , Madrid , Spain
| | - J Gimeno
- Virgin of the Arrixaca University Clinical Hospital, Inherited Cardiac Disease Unit , Murcia , Spain
| | - M Merlo
- University of Trieste, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Integrata Giuliano Isontina , Trieste , Italy
| | - K Wahbi
- Université de Paris, Institut Imagine, AP-HP, Cochin Hospital, Cardiology Department , Paris , France
| | - D Fatkin
- Victor Chang Cardiac Research Institute , Sydney , Australia
| | - J Mogensen
- Aalborg University Hospital , Aalborg , Denmark
| | | | - P Elliott
- University College London & Barts Heart Centre , London , United Kingdom
| |
Collapse
|
4
|
Deb AS, Manju M, Sengupta A, Ali SM. Efficient separation of strontium ions from aqueous solution by dibenzo-18-crown-6 functionalized resin: Static and dynamic adsorption studies with computational DFT insights. Chemical Engineering Journal Advances 2022. [DOI: 10.1016/j.ceja.2022.100308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
5
|
Samanta SK, Das P, Sengupta A, Acharya R. Optimization of external (in air) particle induced gamma-ray emission (PIGE) methodology for rapid, non-destructive, and simultaneous quantification of fluorine, sodium, and phosphorus in nuclear waste immobilization matrices. RSC Adv 2022; 12:32684-32692. [DOI: 10.1039/d2ra06163e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Accepted: 10/25/2022] [Indexed: 11/16/2022] Open
Abstract
External (in air) PIGE methodology has been optimized for rapid quantification of fluorine, sodium, and phosphorus in fluorapatite waste immobilization matrices for Molten Salt Reactor (MSR).
Collapse
Affiliation(s)
- S. K. Samanta
- Radiochemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, India
- HomiBhabha National Institute, Department of Atomic Energy, Mumbai-400094, India
| | - P. Das
- Product Development Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, India
- HomiBhabha National Institute, Department of Atomic Energy, Mumbai-400094, India
| | - A. Sengupta
- Radiochemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, India
- HomiBhabha National Institute, Department of Atomic Energy, Mumbai-400094, India
| | - R. Acharya
- Radiochemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai-400085, India
- HomiBhabha National Institute, Department of Atomic Energy, Mumbai-400094, India
| |
Collapse
|
6
|
Saunderson C, Paton MF, Brown LAE, Gierula J, Chew PG, Das A, Sengupta A, Craven TP, Chowdhary A, Levelt E, Dall"armellina E, Witte KK, Greenwood JP, Plein S, Swoboda PP. Detrimental immediate and long-term clinical effects of right ventricular pacing in patients with myocardial fibrosis. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Long-term right ventricular (RV) pacing leads to heart failure or a decline in left ventricular (LV) function in up to a fifth of patients.
Objectives
We aimed to establish whether patients with focal fibrosis detected on late gadolinium enhancement cardiovascular magnetic resonance (CMR) have deterioration in LV function after RV pacing.
Methods
We recruited 110 patients (84 in final analysis) into two observational CMR studies. Patients (n = 34) with a dual chamber device and preserved atrioventricular (AV) conduction underwent CMR in two asynchronous pacing modes (AOO & DOO) to compare intrinsic conduction with RV pacing. Patients (n = 50) with high-grade AV block underwent CMR before and 6 months after pacemaker implantation to investigate the long-term effects of RV pacing.
Results: The three key findings were
1) Initiation of RV pacing in patients with fibrosis, compared to those without, was associated with greater immediate changes in both LV end-systolic volume index (LVESVi) (5.3 ± 3.5 vs 2.1 ± 2.4 mL/m2; p < 0.01) and LV ejection fraction (LVEF) (-5.7 ± 3.4% vs -3.2 ± 2.6%; p = 0.02); 2) Long-term RV pacing in patients with fibrosis, compared to those without, was associated with greater changes in LVESVi (8.0 ± 10.4 vs -0.6 ± 7.3 mL/m2; p = 0.008) and LVEF (-12.3 ± 7.9 vs -6.7 ± 6.2%; p = 0.012); 3) Patients with fibrosis did not experience an improvement in quality of life, biomarkers or functional class after pacemaker implantation.
Conclusions
Fibrosis detected on CMR is associated with immediate and long-term deterioration in LV function following RV pacing and could be used to identify those at risk of heart failure prior to pacemaker implantation.
Characteristics before and after pacing Study 1 No fibrosis (n = 16) Fibrosis (n = 18) AOO DOO p-value AOO DOO p-value LVEDVi - mL/m² 66 ± 13 66 ± 12 0.67 78 ± 14 79 ± 13 0.34 LVESVi - mL/m² 30 ± 10 32 ± 9 0.003 38 ± 11 43 ± 12 <0.001 LVEF - % 56 ± 6 53 ± 5 <0.001 52 ± 8 47 ± 9 <0.001 Mechanical Dyssynchrony index - ms 61 ± 17 71 ± 25 0.07 81 ± 18 89 ± 21 0.04 Study 2 No fibrosis (n = 19) Fibrosis (n = 31) Pre-PPM Post-PPM p-value Pre-PPM Post-PPM p-value LVEDVi -mL/m² 88 ± 21 73 ± 14 <0.001 90 ± 18 83 ± 21 0.007 LVESVi -mL/m² 35 ± 9 34 ± 9 0.71 41 ± 14 49 ± 21 0.001 LVEF - % 60 ± 5 54 ± 7 <0.001 56 ± 8 43 ± 12 <0.001 Mechanical Dyssynchrony index - ms 70 ± 29 81 ± 22 0.15 84 ± 30 98 ± 31 0.03 Abstract Figure. Mechanism for heart failure after pacing
Collapse
Affiliation(s)
- C Saunderson
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - MF Paton
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - LAE Brown
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - J Gierula
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - PG Chew
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - A Das
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - A Sengupta
- Leeds General Infirmary, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - TP Craven
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - A Chowdhary
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - E Levelt
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - E Dall"armellina
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - KK Witte
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - JP Greenwood
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - S Plein
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - PP Swoboda
- University of Leeds, Leeds, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
7
|
Sharma V, Al Saikhan L, Park C, Hughes A, Gu H, Saeed S, Boguslavskyi A, Carr-White G, Chambers J, Chowienczyk P, Jain M, Jessop H, Turner C, Bassindale-Maguire G, Baig W, Kidambi A, Abdel-Rahman ST, Schlosshan D, Sengupta A, Fitzpatrick A, Sandoval J, Hickman S, Procter H, Taylor J, Kaur H, Knowles C, Wheatcroft S, Witte K, Gatenby K, Willis JA, Kendler-Rhodes A, Slegg O, Carson K, Easaw J, Kandan SR, Rodrigues JCL, MacKenzie-Ross R, Hall T, Robinson G, Little D, Hudson B, Pauling J, Redman S, Graham R, Coghlan G, Suntharalingam J, Augustine DX, Nowak JWM, Masters AT. Report from the Annual Conference of the British Society of Echocardiography, October 2018, ACC Liverpool, Liverpool. Echo Res Pract 2020; 7:M1. [PMID: 33112840 PMCID: PMC8693154 DOI: 10.1530/erp-20-0037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Affiliation(s)
- V Sharma
- Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - L Al Saikhan
- MRC Unit for Lifelong Health and Aging at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.,Department of Cardiac Technology, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - C Park
- MRC Unit for Lifelong Health and Aging at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK
| | - A Hughes
- MRC Unit for Lifelong Health and Aging at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK
| | - H Gu
- British Heart Foundation Centre, King's College London, London, UK
| | - S Saeed
- Haukeland University Hospital, Bergen, Norway
| | - A Boguslavskyi
- British Heart Foundation Centre, King's College London, London, UK
| | - G Carr-White
- British Heart Foundation Centre, King's College London, London, UK.,Cardiothoracic Centre, St Thomas' Hospital, London, UK
| | - J Chambers
- Cardiothoracic Centre, St Thomas' Hospital, London, UK
| | - P Chowienczyk
- British Heart Foundation Centre, King's College London, London, UK
| | - M Jain
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK
| | - H Jessop
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK
| | - C Turner
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK.,Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | | | - W Baig
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK
| | - A Kidambi
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK
| | | | - D Schlosshan
- Yorkshire Heart Centre, Leeds General Infirmary, Leeds, UK
| | - A Sengupta
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - A Fitzpatrick
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - J Sandoval
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - S Hickman
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - H Procter
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - J Taylor
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - H Kaur
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - C Knowles
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - S Wheatcroft
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - K Witte
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - K Gatenby
- Department of Cardiology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - J A Willis
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | | | - O Slegg
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - K Carson
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - J Easaw
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - S R Kandan
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | | | | | - T Hall
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - G Robinson
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - D Little
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - B Hudson
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - J Pauling
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - S Redman
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - R Graham
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - G Coghlan
- Department of Cardiology, Royal Free Hospital, London, UK
| | - J Suntharalingam
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK.,University of Bath, Bath, UK
| | - D X Augustine
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - J W M Nowak
- Royal United Hospitals Bath, NHS Foundation Trust, Bath, UK
| | - A T Masters
- University Hospitals Bristol NHS Foundation Trust, Bristol, UK
| |
Collapse
|
8
|
Sengupta A, Lim DC, Keenan BT, Keele L, Pack A, Weljie A. 0054 Metabolite Profiles of Obstructive Sleep Apnea Distinguishes Cases from Controls and Improve With CPAP. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Obstructive sleep apnea (OSA) is a common sleep breathing disorder with significant public health consequences. Despite this, no clinically available objective molecular biomarkers to diagnose, risk stratify and quantify treatment efficiency exist. To this end, high-throughput metabolomics data could serve as a valuable quantitative tool.
Methods
We designed a pilot study to investigate the metabolomic effects of OSA and CPAP treatment. Blood serum samples were collected from OSA patients and healthy controls matched with respect to age (±5 years), BMI (±2.5 kg/m2) and gender (N = 20/group). Samples from OSA patients were obtained before and after continuous positive airway pressure (CPAP) treatment. Polar metabolites were analyzed using a targeted ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) metabolomics technique.
Results
Supervised multivariate analysis using serum metabolic values of OSA patients and healthy controls showed a significantly different overall metabolic profile between the two groups (orthogonal partial least squares discriminant analysis [OPLS-DA] Q2=0.25, p=0.04). Acetylornithine, choline, cytidine, dodecenoylcarnitine, methionine sulfoxide and 3-indoxylsulfate were among the most perturbed metabolites. Major metabolic pathways altered in the OSA patients were methionine and phospholipid metabolism, as well as gut microbial co-metabolism. Lysophosphatidylcholine (16:0), a phospholipid metabolite, demonstrated significant linear association with improved oxygen saturation nadir post CPAP treatment (R2 = 0.57), suggesting the metabolic features may be used as prognostic clinical biomarkers.
Conclusion
These results suggest that OSA significantly impacts blood metabolites, which could potentially be used to establish OSA biomarkers. Moreover, specific metabolic features are associated with post CPAP improvement, such as phospholipids, suggesting a functional association of these metabolites that may help us understand the heterogeneity of OSA. Overall, these results demonstrate the potential of metabolic profiling to develop quantitative molecular markers of OSA. Further studies are underway to validate these findings and investigate the utility of metabolic profiles to objectively measure CPAP efficacy.
Support
The work was supported by the program project grant P01 HL094307.
Collapse
Affiliation(s)
- A Sengupta
- University of Pennsylvania, Philadelphia, PA
| | - D C Lim
- University of Pennsylvania, Philadelhia, PA
| | - B T Keenan
- University of Pennsylvania, Philadelhia, PA
| | - L Keele
- University of Pennsylvania, Philadelhia, PA
| | - A Pack
- University of Pennsylvania, Philadelhia, PA
| | - A Weljie
- University of Pennsylvania, Philadelhia, PA
| |
Collapse
|
9
|
Sengupta A, Tudor JC, Cusmano D, Baur JA, Abel T, Weljie A. 0346 Metabolic Aging and Sleep Loss: Metabolite Signatures Link Sleep Deprivation and Aging Across Tissues. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Insufficient sleep is a hallmark of modern society, and sleep deprivation (SD) is a risk factor for neurodegenerative and cardiometabolic disorders. The interactions of aging with systemic and local metabolic alterations induced by sleep deprivation are essentially unexplored. In this study, we demonstrate a shared metabolic imprint of SD and aging in plasma, liver, and hippocampus.
Methods
Young (2 - 4 months) and aged (22 - 24 months) mice were sleep deprived (N = 10/group) for 5 hours followed by collection of blood plasma, liver and hippocampus. The samples were extracted and subjected to UPLC-MS/MS based targeted metabolomics analysis.
Results
Young animals displayed greater sensitivity to SD induced metabolic changes with >40% more metabolites perturbed in each sample type measured compared to aged animals. Enrichment analysis based on known disease-associated metabolites suggests that plasma change in young animals are of pathological relevance, but not in aged animals. A common hepatic signature of sleep-loss across the two age groups consisted of ketosis and urea cycle perturbation. Approximately 20-30% of measured metabolites exhibit similar changes when the sleep deprivation induced signature is compared with the aging metabolic imprint in a tissue-dependent manner. Central energetics, urea cycle and aromatic amino acid metabolism highlight the common pathways altered by sleep and aging in the periphery. In the hippocampus, choline and acetylcholine pools were depleted, potentially providing insight into the changes in metabolism that accompany analogous defects in memory consolidation.
Conclusion
These results support the notion that SD makes the ‘young seem old’. The results further connect neurobehavioral observations tying together aging and sleep loss, by implicating molecular mechanisms at the level of metabolism.
Support
This work was supported by NIH grant R21AG052905 (AMW, AS), P50AG017628 (TA; A.I. Pack, PI) and R01AG062398 (TA, JT). TA was supported by the Brush Family Chair in Biology at Penn and is currently supported by the Roy J. Carver Chair of Neuroscience at Iowa.
Collapse
Affiliation(s)
- A Sengupta
- University of Pennsylvania, Philadelphia, PA
| | - J C Tudor
- Saint Joseph’s University, Philadelphia, PA
| | - D Cusmano
- University of Pennsylvania, Philadelphia, PA
| | - J A Baur
- University of Pennsylvania, Philadelphia, PA
| | - T Abel
- University of Iowa, Iowa City, IA
| | - A Weljie
- University of Pennsylvania, Philadelphia, PA
| |
Collapse
|
10
|
Hawkins R, Shatil AS, Lee L, Sengupta A, Zhang L, Morrow S, Aviv RI. Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment. AJNR Am J Neuroradiol 2020; 41:449-455. [PMID: 32079601 DOI: 10.3174/ajnr.a6435] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Accepted: 01/11/2020] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Graph theory uses structural similarity to analyze cortical structural connectivity. We used a voxel-based definition of cortical covariance networks to quantify and assess the relationship of network characteristics to cognition in a cohort of patients with relapsing-remitting MS with and without cognitive impairment. MATERIALS AND METHODS We compared subject-specific structural gray matter network properties of 18 healthy controls, 25 patients with MS with cognitive impairment, and 55 patients with MS without cognitive impairment. Network parameters were compared, and predictive value for cognition was assessed, adjusting for confounders (sex, education, gray matter volume, network size and degree, and T1 and T2 lesion load). Backward stepwise multivariable regression quantified predictive factors for 5 neurocognitive domain test scores. RESULTS Greater path length (r = -0.28, P < .0057) and lower normalized path length (r = 0.36, P < .0004) demonstrated a correlation with average cognition when comparing healthy controls with patients with MS. Similarly, MS with cognitive impairment demonstrated a correlation between lower normalized path length (r = 0.40, P < .001) and reduced average cognition. Increased normalized path length was associated with better performance for processing (P < .001), learning (P < .001), and executive domain function (P = .0235), while reduced path length was associated with better executive (P = .0031) and visual domains. Normalized path length improved prediction for processing (R 2 = 43.6%, G2 = 20.9; P < .0001) and learning (R 2 = 40.4%, G2 = 26.1; P < .0001) over a null model comprising confounders. Similarly, higher normalized path length improved prediction of average z scores (G2 = 21.3; P < .0001) and, combined with WM volume, explained 52% of average cognition variance. CONCLUSIONS Patients with MS and cognitive impairment demonstrate more random network features and reduced global efficiency, impacting multiple cognitive domains. A model of normalized path length with normal-appearing white matter volume improved average cognitive z score prediction, explaining 52% of variance.
Collapse
Affiliation(s)
- R Hawkins
- From the Department of Medical Imaging (R.H., A.S.S., A.S., L.Z.)
| | - A S Shatil
- From the Department of Medical Imaging (R.H., A.S.S., A.S., L.Z.)
| | - L Lee
- Division of Neurology (L.L.), Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - A Sengupta
- From the Department of Medical Imaging (R.H., A.S.S., A.S., L.Z.)
| | - L Zhang
- From the Department of Medical Imaging (R.H., A.S.S., A.S., L.Z.)
| | - S Morrow
- Division of Neurology (S.M.), Lawson Health Research Institute, London Health Sciences Centre, University Hospital, London, Ontario, Canada
| | - R I Aviv
- Institute of Biomaterials and Biomedical Engineering (R.I.A.), University of Toronto, Toronto, Ontario, Canada .,Department of Radiology (R.I.A.), University of Ottawa, and Division of Neuroradiology, The Ottawa Hospital, Ottawa, Ontario, Canada
| |
Collapse
|
11
|
Horner K, Barry S, Dave M, Dixon C, Littlewood A, Pang CL, Sengupta A, Srinivasan V. Diagnostic efficacy of cone beam computed tomography in paediatric dentistry: a systematic review. Eur Arch Paediatr Dent 2019; 21:407-426. [PMID: 31858481 PMCID: PMC7415745 DOI: 10.1007/s40368-019-00504-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Accepted: 12/10/2019] [Indexed: 01/08/2023]
Abstract
Purpose To determine in which clinical situations it is indicated or contra-indicated to prescribe cone beam computed tomography (CBCT) for paediatric patients. Methods Systematic review of in vivo paediatric research studies of diagnostic efficacy using CBCT, with supplementary searches for guideline documents on CBCT and for systematic reviews permitting inclusion of ex vivo and adult studies. Results After screening, 190 publications were included, mostly case studies. No systematic reviews were found of in vivo paediatric research. Fourteen studies of diagnostic efficacy were identified. The supplementary searches found 18 guideline documents relevant to the review and 26 systematic reviews. The diagnostic efficacy evidence on CBCT was diverse and often of limited quality. There was ex vivo evidence for diagnostic accuracy being greater using CBCT than radiographs for root fractures. The multiplanar capabilities of CBCT are advantageous when localising dental structures for surgical planning. Patient movement during scanning is more common in children which could reduce diagnostic efficacy. Conclusions No strong recommendations on CBCT are possible, except that it should not be used as a primary diagnostic tool for caries. Guidelines on use of CBCT in the paediatric age group should be developed cautiously, taking into account the greater radiation risk and the higher economic costs compared with radiography. CBCT should only be used when adequate conventional radiographic examination has not answered the question for which imaging was required. Clinical research in paediatric patients is required at the higher levels of diagnostic efficacy of CBCT. Electronic supplementary material The online version of this article (10.1007/s40368-019-00504-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- K Horner
- Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK.
- Dental Radiology, University Dental Hospital of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Higher Cambridge Street, Manchester, M15 6FH, UK.
| | - S Barry
- Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK
- Paediatric Dentistry, University Dental Hospital of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Higher Cambridge Street, Manchester, M15 6FH, UK
| | - M Dave
- Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK
| | - C Dixon
- Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK
- Paediatric Dentistry, University Dental Hospital of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Higher Cambridge Street, Manchester, M15 6FH, UK
| | - A Littlewood
- Information Specialist, Cochrane Oral Health, Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK
| | - C L Pang
- Division of Imaging, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9WL, UK
| | - A Sengupta
- Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Coupland Building 3, Manchester, M13 9PL, UK
- Dental Radiology, University Dental Hospital of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Higher Cambridge Street, Manchester, M15 6FH, UK
| | - V Srinivasan
- Paediatric Dentistry, University Dental Hospital of Manchester, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Higher Cambridge Street, Manchester, M15 6FH, UK
| |
Collapse
|
12
|
Plevris N, Chuah CS, Allen RM, Arnott ID, Brennan PN, Chaudhary S, Churchhouse AMD, Din S, Donoghue E, Gaya DR, Groome M, Jafferbhoy HM, Jenkinson PW, Lam WL, Lyons M, Macdonald JC, MacMaster M, Mowat C, Naismith GD, Potts LF, Saffouri E, Seenan JP, Sengupta A, Shasi P, Sutherland DI, Todd JA, Veryan J, Watson AJM, Watts DA, Jones GR, Lees CW. Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort. J Crohns Colitis 2019; 13:1111-1120. [PMID: 30768123 DOI: 10.1093/ecco-jcc/jjz042] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND & AIMS Vedolizumab is an anti-a4b7 monoclonal antibody that is licensed for the treatment of moderate to severe Crohn's disease and ulcerative colitis. The aims of this study were to establish the real-world effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease. METHODS This was a retrospective study involving seven NHS health boards in Scotland between June 2015 and November 2017. Inclusion criteria included: a diagnosis of ulcerative colitis or Crohn's disease with objective evidence of active inflammation at baseline (Harvey-Bradshaw Index[HBI] ≥5/Partial Mayo ≥2 plus C-reactive protein [CRP] >5 mg/L or faecal calprotectin ≥250 µg/g or inflammation on endoscopy/magnetic resonance imaging [MRI]); completion of induction; and at least one clinical follow-up by 12 months. Kaplan-Meier survival analysis was used to establish 12-month cumulative rates of clinical remission, mucosal healing, and deep remission [clinical remission plus mucosal healing]. Rates of serious adverse events were described quantitatively. RESULTS Our cohort consisted of 180 patients with ulcerative colitis and 260 with Crohn's disease. Combined median follow-up was 52 weeks (interquartile range [IQR] 26-52 weeks). In ulcerative colitis, 12-month cumulative rates of clinical remission, mucosal healing, and deep remission were 57.4%, 47.3%, and 38.5%, respectively. In Crohn's disease, 12-month cumulative rates of clinical remission, mucosal healing, and deep remission were 58.4%, 38.9%, and 28.3% respectively. The serious adverse event rate was 15.6 per 100 patient-years of follow-up. CONCLUSIONS Vedolizumab is a safe and effective treatment for achieving both clinical remission and mucosal healing in ulcerative colitis and Crohn's disease.
Collapse
Affiliation(s)
- N Plevris
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - C S Chuah
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - R M Allen
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - I D Arnott
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - P N Brennan
- Department of Gastroenterology, Ninewells Hospital, Dundee, UK
| | - S Chaudhary
- Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK
| | | | - S Din
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - E Donoghue
- Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK
| | - D R Gaya
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - M Groome
- Department of Gastroenterology, Ninewells Hospital, Dundee, UK
| | - H M Jafferbhoy
- Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK
| | - P W Jenkinson
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.,Department of Colorectal Surgery, Raigmore Hospital, Inverness, UK
| | - W L Lam
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - M Lyons
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - J C Macdonald
- Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK
| | - M MacMaster
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - C Mowat
- Department of Gastroenterology, Ninewells Hospital, Dundee, UK
| | - G D Naismith
- Department of Gastroenterology, Royal Alexandra Hospital, Paisley, UK
| | - L F Potts
- Department of Gastroenterology, Raigmore Hospital, Inverness, UK
| | - E Saffouri
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - J P Seenan
- Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK
| | - A Sengupta
- Department of Gastroenterology, Victoria Hospital, Kirkcaldy, UK
| | - P Shasi
- Department of Gastroenterology, Ninewells Hospital, Dundee, UK
| | - D I Sutherland
- Department of Gastroenterology, University Hospital Hairmyres, East Kilbride, UK
| | - J A Todd
- Department of Gastroenterology, Ninewells Hospital, Dundee, UK
| | - J Veryan
- Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
| | - A J M Watson
- Department of Colorectal Surgery, Raigmore Hospital, Inverness, UK
| | - D A Watts
- Department of Gastroenterology, Forth Valley Royal Hospital, Larbert, UK
| | - G R Jones
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| | - C W Lees
- The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
| |
Collapse
|
13
|
Dora JK, Sengupta A, Ghosh S, Yedla N, Chakraborty J. Stress evolution with concentration-dependent compositional expansion in a silicon lithium-ion battery anode particle. J Solid State Electrochem 2019. [DOI: 10.1007/s10008-019-04353-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Stephenson E, Sekhri N, Sengupta A, Gkosios T, Lorenzini M, Mohiddin SA. P379The value of T1 mapping in the presentation of chest pain with left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez109.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- E Stephenson
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - N Sekhri
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - A Sengupta
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - T Gkosios
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - M Lorenzini
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - S A Mohiddin
- Barts Health NHS Trust, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
15
|
Kumar R, Kumar S, Sengupta A. AN EXPERIMENTAL ANALYSIS AND VALIDATION OF ELECTRICAL IMPEDANCE TOMOGRAPHY TECHNIQUE FOR MEDICAL OR INDUSTRIAL APPLICATION. Biomed Eng Appl Basis Commun 2019. [DOI: 10.4015/s1016237219500108] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Electrical impedance tomography is a recently established technique by which impedance of an object (medical or nonmedical applications) is measured data from the surface of the object, and a numerically simulated reconstruction of the object internal shape of the image can be obtained. This imaging technique based on boundary or surface voltage is measured when the different current pattern is injected into it. For current pulse, we are creating a voltage controlled current source, which is based on the different RC circuits, according to current amplitude and frequency values. The current source used in inject the current pulse of the various phantoms. The current position and measuring voltage is controlled by the created control unit or programmable system on chip (PSOC) of the proposed EIT system. After that image reconstruction of the cross-sectional image of resistivity requires sufficient data collection from used phantoms, which is based on finite element method (FEM) method and Tikhonov regularization method with helps of graphical user interface (GUI) on MatLab. The objective of the GUI was to produce an image (2D/3D), impedance distribution graph, and the FEM mesh model according to used electrode combinations from the various phantoms. EIT system has a great potential for imaging modality, is non-invasive, radiation-free, and inexpensive for medical applications.
Collapse
Affiliation(s)
- Ramesh Kumar
- Department of Instrumentation Control Engineering, Dr. B. R. Ambedkar National Institute of Technology, Jalandhar, India
| | - Sharvan Kumar
- Department of Instrumentation Control Engineering, Dr. B. R. Ambedkar National Institute of Technology, Jalandhar, India
| | | |
Collapse
|
16
|
Best L, Sengupta A, Sargeant J, Murphy R, de Metz C, Ingledew P, Loewen S, Trotter T. Feedback for Transition to Practice Training in Radiation Oncology. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Hao D, Sengupta A, Ding K, Leighl N, Shepherd F, Seymour L, Weljie A. P2.01-055 Examining Metabolomics as a Prognostic Marker in Metastatic Non–Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1157] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Mahasneh SA, Horner K, Cunliffe J, Al-Salehi S, Sengupta A, AlHadidi A. Guidelines on radiographic imaging as part of root canal treatment: a systematic review with a focus on review imaging after treatment. Int Endod J 2017; 51 Suppl 3:e238-e249. [DOI: 10.1111/iej.12857] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Accepted: 09/02/2017] [Indexed: 12/17/2022]
Affiliation(s)
- S. A. Mahasneh
- Division of Dentistry; Faculty of Biology, Medicine and Health; School of Medical Sciences; Manchester Academic Health Science Centre; University of Manchester; Manchester UK
| | - K. Horner
- Division of Dentistry; Faculty of Biology, Medicine and Health; School of Medical Sciences; Manchester Academic Health Science Centre; University of Manchester; Manchester UK
| | - J. Cunliffe
- Division of Dentistry; Faculty of Biology, Medicine and Health; School of Medical Sciences; Manchester Academic Health Science Centre; University of Manchester; Manchester UK
| | - S. Al-Salehi
- Hamdan Bin Mohammed College of Dental Medicine; Mohammed Bin Rashid University of Medicine and Health Sciences; Dubai UAE
| | - A. Sengupta
- Division of Dentistry; Faculty of Biology, Medicine and Health; School of Medical Sciences; Manchester Academic Health Science Centre; University of Manchester; Manchester UK
| | - A. AlHadidi
- School of Dentistry; The University of Jordan; Amman Jordan
| |
Collapse
|
19
|
Sharma SK, Katoch K, Sarin R, Balambal R, Kumar Jain N, Patel N, Murthy KJR, Singla N, Saha PK, Khanna A, Singh U, Kumar S, Sengupta A, Banavaliker JN, Chauhan DS, Sachan S, Wasim M, Tripathi S, Dutt N, Jain N, Joshi N, Penmesta SRR, Gaddam S, Gupta S, Khamar B, Dey B, Mitra DK, Arora SK, Bhaskar S, Rani R. Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial. Sci Rep 2017; 7:3354. [PMID: 28611374 PMCID: PMC5469738 DOI: 10.1038/s41598-017-03514-1] [Citation(s) in RCA: 60] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Accepted: 04/28/2017] [Indexed: 11/09/2022] Open
Abstract
Prolonged treatment of tuberculosis (TB) often leads to poor compliance, default and relapse, converting primary TB patients into category II TB (Cat IITB) cases, many of whom may convert to multi-drug resistant TB (MDR-TB). We have evaluated the immunotherapeutic potential of Mycobacterium indicus pranii (MIP) as an adjunct to Anti-Tubercular Treatment (ATT) in Cat II pulmonary TB (PTB) patients in a prospective, randomized, double blind, placebo controlled, multicentric clinical trial. 890 sputum smear positive Cat II PTB patients were randomized to receive either six intra-dermal injections (2 + 4) of heat-killed MIP at a dose of 5 × 108 bacilli or placebo once in 2 weeks for 2 months. Sputum smear and culture examinations were performed at different time points. MIP was safe with no adverse effects. While sputum smear conversion did not show any statistically significant difference, significantly higher number of patients (67.1%) in the MIP group achieved sputum culture conversion at fourth week compared to the placebo (57%) group (p = 0.0002), suggesting a role of MIP in clearance of the bacilli. Since live bacteria are the major contributors for sustained incidence of TB, the potential of MIP in clearance of the bacilli has far reaching implications in controlling the spread of the disease.
Collapse
Affiliation(s)
| | - Kiran Katoch
- National JALMA Institute of Leprosy and Other Mycobacterial Diseases (ICMR), Agra, India
| | - Rohit Sarin
- National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India
| | - Raman Balambal
- National Institute of Research in Tuberculosis (ICMR), Chennai, India
| | - Nirmal Kumar Jain
- SMS Medical College (Hospital for Chest Diseases and TB), Jaipur, Rajasthan, India
| | - Naresh Patel
- NHL Municipal Medical College, Ahmadabad, Gujarat, India
| | | | - Neeta Singla
- National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India
| | - P K Saha
- All India Institute of Medical Sciences, New Delhi, India
| | - Ashwani Khanna
- All India Institute of Medical Sciences, New Delhi, India
| | - Urvashi Singh
- All India Institute of Medical Sciences, New Delhi, India
| | - Sanjiv Kumar
- All India Institute of Medical Sciences, New Delhi, India
| | - A Sengupta
- All India Institute of Medical Sciences, New Delhi, India.,Chest Clinic and Hospital, New Delhi, India
| | - J N Banavaliker
- All India Institute of Medical Sciences, New Delhi, India.,RBTB Hospital, New Delhi, India
| | - D S Chauhan
- National JALMA Institute of Leprosy and Other Mycobacterial Diseases (ICMR), Agra, India
| | - Shailendra Sachan
- National JALMA Institute of Leprosy and Other Mycobacterial Diseases (ICMR), Agra, India
| | - Mohammad Wasim
- National JALMA Institute of Leprosy and Other Mycobacterial Diseases (ICMR), Agra, India
| | | | - Nilesh Dutt
- NHL Municipal Medical College, Ahmadabad, Gujarat, India
| | - Nitin Jain
- SMS Medical College (Hospital for Chest Diseases and TB), Jaipur, Rajasthan, India
| | - Nalin Joshi
- SMS Medical College (Hospital for Chest Diseases and TB), Jaipur, Rajasthan, India
| | | | - Sumanlatha Gaddam
- Mahavir Hospital and Research Centre, Hyderabad, Andhra Pradesh, India
| | - Sanjay Gupta
- Catalyst Clinical Services Pvt. Ltd., New Delhi, India
| | | | - Bindu Dey
- Department of Biotechnology, New Delhi, India
| | | | - Sunil K Arora
- Post Graduate Institute of Medical Education & Research, Chandigarh, India
| | | | - Rajni Rani
- National Institute of Immunology, New Delhi, India. .,Systems Biology laboratory, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India.
| |
Collapse
|
20
|
Affiliation(s)
- K. Ganguly
- Indian Institute of Technology, Nuclear Engineering and Technology Programme Kanpur, India
| | - A. Sengupta
- Indian Institute of Technology, Nuclear Engineering and Technology Programme Kanpur, India
| |
Collapse
|
21
|
Affiliation(s)
- A. Sengupta
- Indian Institute of Technology, Nuclear Engineering and Technology Program Kanpur 208016, India
| |
Collapse
|
22
|
Affiliation(s)
- K. Ganguly
- Indian Institute of Technology, Nuclear Engineering and Technology Programme Department of Mechanical Engineering, Kanpur, India
| | - A. Sengupta
- Indian Institute of Technology, Nuclear Engineering and Technology Programme Department of Mechanical Engineering, Kanpur, India
| |
Collapse
|
23
|
Sengupta A, Gehrman P, Harders E, Ubeydullah E, Pack A, Weljie AM. 0412 UNITED BY SLEEP ARCHITECTURE, DIVIDED BY METABOLISM: METABOLOMICS OF MILD INSOMNIA. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
24
|
Boda A, Deb A, Sengupta A, Ali S, Shenoy K. Elucidation of complexation of tetra and hexavalent actinides towards an amide ligand in polar and non-polar diluents: Combined experimental and theoretical approach. Polyhedron 2017. [DOI: 10.1016/j.poly.2016.10.055] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Varanasi S, Wright I, Hussain W, Bowers R, Slater T, Sengupta A, Porter B, Hussein A, Chu G, Siddiqui M, Man S, Somani R, Sandilands A, Stafford P, Ng G, Luther V, Young Kim M, Benfield A, Tanner M, Lefroy D, Koa-Wing M, Lim P, Linton N, Davies D, Peters N, Kanagaratnam P, Moore P, Whinnett Z, Thakrar D, Iacovides S, Paisey J, Balasubramaniam R, Sopher SM, Saunderson C, Moyles C, Blackburn Y, Morley C, Jamil H, Schlosshan D, Kearney M, Witte K, Lambden C, Woodcock T, Matthew D, Hashmy S, Kaur M, Kaba A, Grant R, Unger-Graeber B, Khan S, Das M, Wynn G, Morgan M, Waktare J, Hall M, Modi S, Snowdon R, Todd D, Gupta D. MODERATED POSTERS (1)43P WAVE DURATION & SPECTRAL ANALYSIS OF SIGNAL AVERAGED P WAVE: CAN THIS PREDICT RECURRENCE OF PARAOXYSMAL ATRIAL FIBRILLATION AFTER PULMONARY VEIN SIOLATION? A PROSPECTIVE STUDY44ATP INDUCED SLOW VF - A MECHANISM TO EXPLAIN THE ASSOCIATION BETWEEN ATP AND INCREASED MORTALITY45THE USE OF A HANDHELD DEVICE IN IDENTIFYING ATRIAL FIBRILLATION PATIENTS DURING FLU VACCINATION CLINICS46DELIVERY OF A FULL EP SERVICE FROM A DISTRICT GENERAL HOSPITAL SETTING: OUTCOMES FROM A SINGLE CENTRE47THE PREVALENCE OF SODIUM AND FLUID DEPLETION IN PATIENTS WITH RECURRENT SYNCOPE OF PRESUMED HYPOTENSIVE ORIGIN: A SINGLE CENTRE EXPERIENCE48ECHOCARDIOGRAPHY AND RISK STRATIFICATION FOR ICD IMPLANTATION AFTER ST-ELEVATION MYOCARDIAL INFARCTION:OPPORTUNITIES FOR IMPROVEMENT49THE QUALITY AND OUTCOMES FRAMEWORK DATA UNDERESTIMATES AF PREVALENCE AND OVERESTIMATES RATES OF APPROPRIATE THROMBOEMBOLIC PROPHYLAXIS50THE RELATIONSHIP BETWEEN THE EFFECTIVE REFRACTORY PERIOD OF RECONNECTED PULMONARY VEINS AT REPEAT ELECTROPHYSIOLOGY STUDY AND RECURRENCE OF ATRIAL TACHYCARRHYTHMIA BEYOND ONE MONTH AFTER PULMONARY VEIN ISOLATION. Europace 2016. [DOI: 10.1093/europace/euw268] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Sengupta A, Bandyopadhyay D, van Westen C, van der Veen A. An evaluation of risk assessment framework for industrial accidents in India. J Loss Prev Process Ind 2016. [DOI: 10.1016/j.jlp.2015.12.012] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Sengupta A, Mohapatra P, Patil A, Kadam R, Verboom W. Radiation stability of diglycolamide functionalized calix[4]arenes in ionic liquid: Solvent extraction, EPR and GC–MS studies. Sep Purif Technol 2016. [DOI: 10.1016/j.seppur.2016.02.017] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
28
|
Sengupta A, Audiffred M, Heine T, Niehaus TA. Stacking dependence of carrier transport properties in multilayered black phosphorous. J Phys Condens Matter 2016; 28:075001. [PMID: 26809017 DOI: 10.1088/0953-8984/28/7/075001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
We present the effect of different stacking orders on carrier transport properties of multi-layer black phosphorous. We consider three different stacking orders AAA, ABA and ACA, with increasing number of layers (from 2 to 6 layers). We employ a hierarchical approach in density functional theory (DFT), with structural simulations performed with generalized gradient approximation (GGA) and the bandstructure, carrier effective masses and optical properties evaluated with the meta-generalized gradient approximation (MGGA). The carrier transmission in the various black phosphorous sheets was carried out with the non-equilibrium green's function (NEGF) approach. The results show that ACA stacking has the highest electron and hole transmission probabilities. The results show tunability for a wide range of band-gaps, carrier effective masses and transmission with a great promise for lattice engineering (stacking order and layers) in black phosphorous.
Collapse
Affiliation(s)
- A Sengupta
- Advanced Semiconductors and Computational Nanoelectronics Lab, School of VLSI Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah-711 103, India. Institute-I Theoretical Physics, Universität Regensburg, 93040 Regensburg, Germany. Department of Physics and Earth Science, Jacobs University, Bremen, Campus Ring 1, 28759 Bremen, Germany
| | | | | | | |
Collapse
|
29
|
Sengupta A, Roy M, Sarkar A, Mylavarapu S, Modi S, Gupta N, B H, Hossain S, Ansari A, Pandey M, Yadav Y, Sengupta S. Abstract P5-03-03: Designing a novel platinum chemotherapeutic (IO-125) for treatment of breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p5-03-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Triple-negative breast cancer (TNBC) is an aggressive form of cancer occurring in 15-20% of breast cancer patients, with most patients relapsing on currently approved therapy. Recent studies have shown activity of platinum chemotherapy in this class of patients. IO-125 is a novel platinum (II) chemotherapeutic agent with an unique coordination environment. In this study, we investigated the anti-tumor activity of IO-125 in pre-clinical models of TNBC.
The coordination environment in IO-125 facilitates supramolecular assembly and releases diaminocyclohexane (DACH)-platinum in a sustained pH-dependent manner. In vitro cell viability studies using an array of breast cancer cell lines shows IO-125 exerts increased potency compared to carboplatin or oxaliplatin. The maximum tolerated (platinum-equivalent) dose (MTD) of IO-125 in mice was 8-fold higher than the MTD (platinum-equivalent) dose of oxaliplatin. The biodistribution and pharmacokinetic profile of IO-125 in plasma and tumor revealed preferential tumor accumulation, significantly increased area-under-the-curve (AUC), a reduction in clearance (CL) and a longer terminal half-life (42 hours) in comparison to oxaliplatin (18 hours). In addition, DNA-Pt adduct formation in tumors was significantly higher for IO-125. When administered at their respective MTDs, IO-125 led to sustained regression of the tumor in a 4T1 syngeneic breast cancer model. Based on these observations, we conclude that IO-125 may emerge as a novel therapeutic against triple negative breast cancer.
Citation Format: Sengupta A, Roy M, Sarkar A, Mylavarapu S, Modi S, Gupta N, B H, Hossain S, Ansari A, Pandey M, Yadav Y, Sengupta S. Designing a novel platinum chemotherapeutic (IO-125) for treatment of breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P5-03-03.
Collapse
Affiliation(s)
- A Sengupta
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - M Roy
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - A Sarkar
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - S Mylavarapu
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - S Modi
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - N Gupta
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - H B
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - S Hossain
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - A Ansari
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - M Pandey
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - Y Yadav
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| | - S Sengupta
- Invictus Oncology Pvt Ltd, New Delhi, Delhi, India; India Innovation Research Center, New Delhi, Delhi, India; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
| |
Collapse
|
30
|
Chen RJ, Kelly G, Sengupta A, Heydendael W, Nicholas B, Beltrami S, Luz S, Peixoto L, Abel T, Bhatnagar S. MicroRNAs as biomarkers of resilience or vulnerability to stress. Neuroscience 2015. [PMID: 26208845 DOI: 10.1016/j.neuroscience.2015.07.045] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Identifying novel biomarkers of resilience or vulnerability to stress could provide valuable information for the prevention and treatment of stress-related psychiatric disorders. To investigate the utility of blood microRNAs as biomarkers of resilience or vulnerability to stress, microRNAs were assessed before and after 7days of chronic social defeat in rats. Additionally, microRNA profiles of two important stress-regulatory brain regions, the medial prefrontal cortex (mPFC) and basolateral amygdala (BLA), were assessed. Rats that displayed vulnerability to subsequent chronic stress exhibited reductions in circulating miR-24-2-5p, miR-27a-3p, miR-30e-5p, miR-3590-3p, miR-362-3p, and miR-532-5p levels. In contrast, rats that became resilient to stress displayed reduced levels of miR-139-5p, miR-28-3p, miR-326-3p, and miR-99b-5p compared to controls. In the mPFC, miR-126a-3p and miR-708-5p levels were higher in vulnerability compared to resilient rats. In the BLA, 77 microRNAs were significantly altered by stress but none were significantly different between resilient and vulnerable animals. These results provide proof-of-principle that assessment of circulating microRNAs is useful in identifying individuals who are vulnerable to the effects of future stress or individuals who have become resilient to the effects of stress. Furthermore, these data suggest that microRNAs in the mPFC but not in the BLA are regulators of resilience/vulnerability to stress.
Collapse
Affiliation(s)
- R J Chen
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - G Kelly
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - A Sengupta
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - W Heydendael
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - B Nicholas
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - S Beltrami
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - S Luz
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States
| | - L Peixoto
- Department of Biology, University of Pennsylvania, United States
| | - T Abel
- Department of Biology, University of Pennsylvania, United States
| | - S Bhatnagar
- Department of Anesthesiology, Children's Hospital of Philadelphia, United States; Department of Anesthesiology, University of Pennsylvania, Perelman School of Medicine, United States.
| |
Collapse
|
31
|
Shah P, Viswambharan H, Gatenby VK, Imrie H, Haywood N, Galloway S, Sengupta A, Cubbon RM, Gage M, Skromna A, Makova N, Grant P, Yuldasheva N, Beech DJ, Wheatcroft SB, Kearney MT. ENDOTHELIAL-SPECIFIC OVEREXPRESSION OF MUTATED INSULIN-LIKE GROWTH FACTOR-1 RECEPTORS (IGF-1R) ENHANCES ENDOTHELIAL INSULIN SENSITIVITY AND VASCULAR HYDROGEN PEROXIDE GENERATION. Heart 2014. [DOI: 10.1136/heartjnl-2014-306916.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
32
|
Jagasia P, Mohapatra PK, Dhami PS, Patil AB, Adya VC, Sengupta A, Gandhi PM, Wattal PK. Studies on the radiolytic stability of newly developed solvent systems containing four calix-crown-6 ligands for radio-cesium recovery. J Radioanal Nucl Chem 2014. [DOI: 10.1007/s10967-014-3316-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
33
|
Chakraborty A, Sengupta A, Bhadu MK, Pandey A, Mondal A. Efficient removal of arsenic (V) from water using steel-making slag. Water Environ Res 2014; 86:524-531. [PMID: 25109198 DOI: 10.2175/106143014x13975035524907] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
This study describes the potential use of steel-making slag as an arsenic-removal medium. Systematic analysis of slag material revealed a composition of oxides of calcium, iron, silicon, and phosphorous. Under the experimental conditions of this study, the equilibrium time was shown to be 2 hours, and the removal capacity to be 99%, with an adsorbent loading capacity of 1.25g/l. The adsorption kinetics were shown to follow a pseudo-second-order rate equation, and the adsorption isotherm closely followed both the Langmuir and Freundlich isothermic models. Variations in solution pH levels demonstrated that with a decrease in the initial solution pH, the adsorption capacity decreases. This is attributed to the leaching of silica and phosphate from the slag to the solution, which imparted a competing effect for adsorption sites. However, with an alkaline pH, such leaching was reduced, and due to formation of calcium carbonate from the leached calcium from the slag material, the arsenic removal efficiency increased as it was co-precipitated with calcium carbonate.
Collapse
|
34
|
Camuglia AC, Luis SA, Sengupta A, Bett JHN, Walters DL. Pre-hospital fibrinolysis in the management of patients with ST elevation acute coronary syndrome: review of the evidence, implementation and future directions. Cardiovasc Hematol Disord Drug Targets 2013; 13:243-255. [PMID: 24479721 DOI: 10.2174/1871529x1303140129155809] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2013] [Revised: 08/10/2013] [Accepted: 09/11/2013] [Indexed: 06/03/2023]
Abstract
Time to reperfusion is among the strongest predictors of clinical outcome in patients who present with ST elevation acute myocardial infarction. When time to access is equivalent, primary percutaneous coronary intervention has demonstrated superior outcomes to fibrinolysis. However, where significant delays exist in accessing percutaneous intervention, fibrinolysis has an important role. The potential for fibrinolysis delivery in the pre-hospital setting means that delays to primary percutaneous intervention need to be considered from the time that the patient becomes eligible for fibrinolysis in the field. This can be particularly challenging in patients with symptom duration ofless than two hours, as some evidence suggests fibrinolysis may be particularly beneficial in this early phase. Additionally, access to primary percutaneous intervention provided by an experienced operator, in a timely manner at any time of the day or night, is not an available option in many healthcare settings. This review focuses on the current evidence and practice of pre-hospital fibrinolysis and assesses potential roles for this therapy in the future.
Collapse
Affiliation(s)
| | | | | | | | - D L Walters
- Director of Cardiology, The Prince Charles Hospital, Rode Rd, Chermside, Brisbane, Queensland, Australia.
| |
Collapse
|
35
|
Taniguchi Ishikawa E, Chang KH, Nayak R, Olsson HA, Ficker AM, Dunn SK, Madhu MN, Sengupta A, Whitsett JA, Grimes HL, Cancelas JA. Klf5 controls bone marrow homing of stem cells and progenitors through Rab5-mediated β1/β2-integrin trafficking. Nat Commun 2013; 4:1660. [PMID: 23552075 PMCID: PMC3627399 DOI: 10.1038/ncomms2645] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2012] [Accepted: 02/22/2013] [Indexed: 01/05/2023] Open
Abstract
Kruppel-like factor 5 (Klf5) regulates pluripotent stem cell self-renewal but its role in somatic stem cells is unknown. Here we show that Klf5 deficient haematopoietic stem cells and progenitors (HSC/P) fail to engraft after transplantation. This HSC/P defect is associated with impaired bone marrow homing and lodging and decreased retention in bone marrow, and with decreased adhesion to fibronectin and expression of membrane-bound β1/β2-integrins. In vivo inducible gain-of-function of Klf5 in HSCs increases HSC/P adhesion. The expression of Rab5 family members, mediators of β1/β2-integrin recycling in the early endosome, is decreased in Klf5Δ/Δ HSC/Ps. Klf5 binds directly to the promoter of Rab5a/b and overexpression of Rab5b rescues the expression of activated β1/β2-integrins, adhesion and bone marrow homing of Klf5Δ/Δ HSC/Ps. Altogether, these data indicate that Klf5 is indispensable for adhesion, homing, lodging and retention of HSC/Ps in the bone marrow through Rab5-dependent post-translational regulation of β1/β2 integrins.
Collapse
Affiliation(s)
- E Taniguchi Ishikawa
- Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0055, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Heydendael W, Sengupta A, Beck S, Bhatnagar S. Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol Behav 2013; 130:182-90. [PMID: 24140988 DOI: 10.1016/j.physbeh.2013.10.005] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2013] [Revised: 08/23/2013] [Accepted: 10/10/2013] [Indexed: 10/26/2022]
Abstract
Maladaptation to stress is associated with psychopathology. However, our understanding of the underlying neural circuitry involved in adaptations to stress is limited. Previous work from our lab indicated the paraventricular hypothalamic neuropeptides orexins/hypocretins regulate behavioral and neuroendocrine responses to stress. To further elucidate the role of orexins in adaptation to stress, we employed optogenetic techniques to specifically examine the effects of orexin cell activation on behavior in the social interaction test and in the home cage as well as orexin receptor 1 internalization and ERK phosphorylation in brain regions receiving orexin inputs. In the social interaction test, optogenetic stimulation of orexin neurons decreased time spent in the interaction zone while increasing the frequency of entries into the interaction zone. In addition, optogenetic stimulation of orexin neurons increased the total distance traveled in the social interaction arena but had no effect on their home cage behavior. Together, these results suggest that orexin release increases anxiety in the social interaction test while increasing the salience of novel but not familiar environmental stimuli. Consistent with activation of orexin neurons, optogenetic stimulation increased orexin receptor1 internalization and ERK phosphorylation in the paraventricular thalamus (PVT) and locus coeruleus (LC), two regions heavily innervated by orexin neurons. Together these results show for the first time that elevation of orexin activity, possibly in the PVT and LC, is associated with increased anxiety, activity, and arousal in a context-specific manner.
Collapse
Affiliation(s)
- W Heydendael
- Children's hospital of Philadelphia, United States; University of Pennsylvania, United States.
| | - A Sengupta
- Children's hospital of Philadelphia, United States
| | - S Beck
- Children's hospital of Philadelphia, United States; University of Pennsylvania, United States
| | - S Bhatnagar
- Children's hospital of Philadelphia, United States; University of Pennsylvania, United States
| |
Collapse
|
37
|
Viswambharan H, Sukumar P, Gage M, Sengupta A, Imrie H, Yuldasheva N, Galloway S, Cubbon R, Wheatcroft S, Kearney MT. Enhancing endothelial insulin sensitivity reduces NO bioavailability: a role for NADPH oxidase-derived reactive oxygen species. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Sengupta A, Viswambharan H, Yuldasheva N, Mercer B, Aziz A, Imrie H, Gage M, Gatenby V, Skromna A, Wheatcroft S, Kearney M, Cubbon R. 163 VASCULAR ENDOTHELIAL INSULIN SENSITISATION REDUCES BLOOD PRESSURE AND PROMOTES ENDOTHELIAL REPAIR IN THE CONTEXT OF GLOBAL INSULIN RESISTANCE. Heart 2013. [DOI: 10.1136/heartjnl-2013-304019.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
39
|
Viswambharan H, Sukumar P, Gage M, Imrie H, Sengupta A, Turner J, Yuldasheva N, Skromna A, Galloway S, Smith J, Cubbon R, Wheatcroft S, Kearney M. 171 NOX2-DERIVED REACTIVE OXYGEN SPECIES CAUSES VASCULAR DYSFUNCTION IN MURINE MODEL OF ENDOTHELIAL INSULIN SENSITIVITY AND ACTIVATION OF NRF2 TRANSCRIPTION FACTOR. Heart 2013. [DOI: 10.1136/heartjnl-2013-304019.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
40
|
Dey A, Biswas D, Saha SK, Kundu S, Kundu S, Sengupta A. Comparison study of clinicoradiological profile of primary lung cancer cases: an Eastern India experience. Indian J Cancer 2012; 49:89-95. [PMID: 22842174 DOI: 10.4103/0019-509x.98930] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
CONTEXT According to the first population-based cancer registry from eastern part of India, Kolkata and its surrounding areas have the highest prevalence of lung cancer in India. However, there is very limited data from this part of the country. AIMS The aim of this study is to find out the demographic and clinicoradiological profile of primary bronchogenic carcinoma. SETTINGS AND DESIGN This is a retrospective review of lung cancer cases diagnosed in two tertiary institutes of Kolkata over a period of 4 years. MATERIALS AND METHODS We have reviewed the cases with proven histological or cytological diagnosis of primary bronchogenic carcinoma and chi-square test is done to calculate statistical significance. RESULTS Out of 607 patients, male 489 and female 118, 67.7% are from rural area, 67.2% are smoker and only 9.4% are ≤40 years of age. Smoking is the major risk factor for primary lung cancer (P = 0.000) but no significance could be established with the different histological subtypes (P = 0.207). Though squamous cell carcinoma (SCC) is the most predominant variety (35.1%), adenocarcinoma and undifferentiated type are overrepresented in ≤40 years. SCC occurs at a significantly higher age group (60.84 ± 12.16 years) than other subtypes (P = 0.000). At least 55.2% cases of nonsmall cell lung cancer and 54% of small cell lung cancer presented in very advanced stage. CONCLUSIONS SCC is the most common histological subtype of primary bronchogenic carcinoma. The relatively increased frequency of adenocarcinoma in our study as compared to other studies from India is probably due to higher proportion of nonsmokers.
Collapse
Affiliation(s)
- A Dey
- Deptartment of Chest Medicine, Calcutta National Medical College, Kolkata, India
| | | | | | | | | | | |
Collapse
|
41
|
Heydendael W, Sengupta A, Bhatnagar S. Putative genes mediating the effects of orexins in the posterior paraventricular thalamus on neuroendocrine and behavioral adaptations to repeated stress. Brain Res Bull 2012; 89:203-10. [PMID: 22982687 DOI: 10.1016/j.brainresbull.2012.09.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Revised: 08/23/2012] [Accepted: 09/04/2012] [Indexed: 01/22/2023]
Abstract
Exposure to repeated stress is often associated with psychopathology. However, our understanding of the underlying neural circuitry that regulates responses to repeated stress is limited. The posterior paraventricular thalamus (pPVT) is a brain region responsible for transmission of multimodal sensory information to limbic structures that regulate responses to both acute and repeated stress. Orexin-containing cells originating in the hypothalamus heavily innervate the pPVT. Our previous work has shown that activation of orexin1 receptors in the pPVT during repeated swim stress is important for facilitation of the hypothalamic-pituitary-adrenal (HPA) axis response to subsequent novel restraint. However, the genes responsible for these orexin-mediated adaptations to repeated stress are not known. Using a custom PCR array we examined the expression of 186 specific mRNAs in the pPVT of animals exposed to repeated swim stress (4 days of 15min swim/day) with or without direct pPVT microinfusion of the orexin1 receptor antagonist SB334867 prior to each daily swim stress. Tissue was collected the next morning under basal non stressed conditions. Repeated stress and/or orexin receptor blockade significantly altered expression of only 9 specific genes including growth factors (Vegfa, Bax and Mt3), G-protein coupled receptors (Adora2a, Grm2 and Crhr1), immune-related genes (Ptgs2 and Cx3cr1) and an epigenetic-related gene (Hdac5). These genes represent potential targets for further characterization of orexin-mediated adaptations to repeated stress in the pPVT.
Collapse
Affiliation(s)
- W Heydendael
- Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia Research Institute and the University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4399, United States
| | | | | |
Collapse
|
42
|
Adya VC, Sengupta A, Ansari S, Mohapatra PK, Bhide MK, Godbole SV. Application of hollow fiber supported liquid membrane for the separation of americium from the analytical waste. J Radioanal Nucl Chem 2012. [DOI: 10.1007/s10967-012-1921-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Sengupta A, Sarkar DK. Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells. J Endocrinol 2012; 214:67-78. [PMID: 22573829 DOI: 10.1530/joe-12-0125] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The neurotransmitter dopamine (DA) is known to inhibit prolactin (PRL) secretion and the proliferation of lactotropes in the pituitary gland. Dopamine-2 (D2) receptor short (D2S) isoform is expressed in a reduced level while the D2 receptor long (D2L) isoform is expressed in an elevated level during estradiol (E(2))-induced PRL production and cell proliferation in lactotropes. To evaluate the role of these D2 receptor isoforms in E(2)-regulated lactotropic cell function, we compared E(2) effects on the level of PRL, cell proliferation, and G proteins in enriched lactotropes and lactotrope-derived PR1 cells containing only D2S isoform (D2S cells), D2L isoform (D2L cells), or no D2 receptor (V cells). Additionally, we determined the effects of G protein blockade on the E(2)-induced PRL production and cell proliferation in these cells. We here show that E(2) actions on G proteins, PRL production, and cell proliferation were maximally achieved in D2S cells, oppositely or marginally achieved in D2L cells, and absent in V cells. We also show that the DA and pertussis toxin modulations of E(2) actions on PRL, G proteins, and cell proliferation were maximally achieved in D2S cells compared with in D2L or V cells. Furthermore, we provide evidence for the existence of an inhibitory action of Gi3 on Gs that is under the control of the D2S receptor and is inhibited by E(2). These results suggest that the suppression of D2S-regulated Gi3 inhibition of Gs protein may be one of the mechanisms controlling E(2)-activated PRL synthesis and cell proliferation in lactotropes.
Collapse
MESH Headings
- Animals
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation/drug effects
- Cells, Cultured
- Dopamine/pharmacology
- Dose-Response Relationship, Drug
- Estradiol/pharmacology
- Estrogens/pharmacology
- Female
- GTP-Binding Protein alpha Subunits, Gi-Go/genetics
- GTP-Binding Protein alpha Subunits, Gi-Go/metabolism
- GTP-Binding Protein alpha Subunits, Gs/genetics
- GTP-Binding Protein alpha Subunits, Gs/metabolism
- Gene Expression/drug effects
- Lactotrophs/cytology
- Lactotrophs/drug effects
- Lactotrophs/metabolism
- Pertussis Toxin/pharmacology
- Prolactin/genetics
- Prolactin/metabolism
- Protein Binding/drug effects
- Protein Isoforms/genetics
- Protein Isoforms/metabolism
- RNA Interference
- Rats
- Rats, Inbred F344
- Receptors, Dopamine D2/genetics
- Receptors, Dopamine D2/metabolism
- Reverse Transcriptase Polymerase Chain Reaction
Collapse
Affiliation(s)
- A Sengupta
- Endocrinology Program and Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Farm Road, New Brunswick, New Jersey 08901, USA
| | | |
Collapse
|
44
|
Sengupta A, Saha K, Jash D, Bandyopadhyay A. Pulmonary Cavity due to Chronic Eosinophilic Pneumonia Associated with Arsenicosis. JNMA J Nepal Med Assoc 2012. [DOI: 10.31729/jnma.52] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
In developing country like India arsenic poisoning is a major public health problem. Association of chronic eosinophilic pneumonia and chronic diarrhea with arsenicosis is rare. Also pulmonary cavity formation in chronic eosinophilic pneumonia is very uncommon. A 44-year-old male patient, resident of an arsenic affected area was admitted for evaluation of chronic diarrhoea, persistent peripheral eosinophilia along with radiologically visible cavity in right upper zone. There were dermatological manifestations of arsenicosis along with presence of noncirrhotic portal fibrosis and peripheral eosinophilia. On bronchoalveolar lavage study, eosinophil comprised 40% of total cellularity making the diagnosis of chronic eosinophilic pneumonia. After ruling out all possible causes of diarrhoea and chronic eosinophilic pneumonia, we came to conclusion that arsenic could be implicated as causative agent.
Keywords: Arsenicosis, chronic diarrhoea, chronic eosinophilic pneumonia, noncirrhotic portal fibrosis.
Collapse
|
45
|
Gujar RB, Ansari SA, Prabhu DR, Pathak PN, Sengupta A, Thulasidas SK, Mohapatra PK, Manchanda VK. Actinide Partitioning with a Modified TODGA Solvent: Counter-Current Extraction Studies with Simulated High Level Waste. Solvent Extraction and Ion Exchange 2012. [DOI: 10.1080/07366299.2011.609392] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
Sengupta A, Mohapatra PK, Iqbal M, Verboom W, Huskens J, Godbole SV. Extraction of Am(iii) using novel solvent systems containing a tripodal diglycolamide ligand in room temperature ionic liquids: a ‘green’ approach for radioactive waste processing. RSC Adv 2012. [DOI: 10.1039/c2ra20577g] [Citation(s) in RCA: 91] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
47
|
Sengupta A, Saha K, Jash D, Bandyopadhyay A. Pulmonary cavity due to chronic eosinophilic pneumonia associated with arsenicosis. JNMA J Nepal Med Assoc 2012; 52:29-32. [PMID: 23279770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
In developing country like India arsenic poisoning is a major public health problem. Association of chronic eosinophilic pneumonia and chronic diarrhea with arsenicosis is rare. Also pulmonary cavity formation in chronic eosinophilic pneumonia is very uncommon. A 44-year-old male patient, resident of an arsenic affected area was admitted for evaluation of chronic diarrhoea, persistent peripheral eosinophilia along with radiologically visible cavity in right upper zone. There were dermatological manifestations of arsenicosis along with presence of noncirrhotic portal fibrosis and peripheral eosinophilia. On bronchoalveolar lavage study, eosinophil comprised 40% of total cellularity making the diagnosis of chronic eosinophilic pneumonia. After ruling out all possible causes of diarrhoea and chronic eosinophilic pneumonia, we came to conclusion that arsenic could be implicated as causative agent.
Collapse
Affiliation(s)
- A Sengupta
- Department of Pulmonary Medicine, NRS Medical College and Hospital, Kolkata, West Bengal, India
| | | | | | | |
Collapse
|
48
|
Sengupta A, Thulasidas SK, Adya VC, Mohapatra PK, Godbole SV, Manchanda VK. Purification of americium from assorted analytical waste in hydrochloric acid medium. J Radioanal Nucl Chem 2011. [DOI: 10.1007/s10967-011-1554-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
|
50
|
Adya VC, Sengupta A, Dhawale BA, Rajeswari B, Thulasidas SK, Godbole SV. Recovery of americium from analytical solid waste containing large amounts of uranium, plutonium and silver. J Radioanal Nucl Chem 2011. [DOI: 10.1007/s10967-011-1360-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|